|Benign Essential Blepharospasm Research Foundation (BEBRF)|
|Home||Blepharospasm||Related disorders||Treatments||Patient support||The BEBRF||FAQ||Blepharospasm
Information in other languages
Other ways to help fund BEBRF
BEBRF on-line store
Blepharospasm Bulletin Board
Subscribe to newsletter
Disclaimer About Medical Advice on This Site
The BEBRF blepharospasm pages are intended to provide information - not to advocate particular treatment options. Thus, it is strongly urged that patients do not change treatment without first consulting their physician.
Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, webmaster and the BEBRF are not responsible for errors or omissions or for any consequences from application of the information on this website and make no warranty, expressed or implied, with respect to the contents of the publication.
The authors, editors, and the BEBRF have exerted every effort to ensure that drug selection and dosage set forth in this site are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug.
Some drugs and medical devices presented on this web site have Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice.Home > Top of this page